Bolodeoku, J., Gbaa, T., Morris, K. and Whitehead, S. 2023. Medicine Optimisation Using PCSK9 Monoclonal Antibodies (alirocumab and evolocumab) Concerning the European Atherosclerosis Society (EAS) of < 1.8 mmol/l LDL Cholesterol Target in a Secondary Care Lipid Clinic. British Journal of Healthcare and Medical Research. 10, 6 (Dec. 2023), 91–102. DOI:https://doi.org/10.14738/bjhmr.106.15955.